Physician profile
James E Wilson
NPI 1265490239
$803.86
in general payments reported to CMS, 2019-2025
16 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $504 · 2020: $179 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $120.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $138.02 | 2020 | |
| Collegium Pharmaceutical, INC. | $137.94 | 2019-2020 | |
| Si-Bone, INC. | $122.22 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $120.56 | 2025 | Eylea Hd |
| Pfizer INC. | $57.69 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $47.43 | 2019-2020 | |
| Fidia Pharma USA INC. | $33.73 | 2019 | |
| Allergan, INC. | $25.63 | 2019 | |
| Scilex Pharmaceuticals INC. | $20.01 | 2019 | |
| Tersera Therapeutics LLC | $17.49 | 2019 | |
| Daiichi Sankyo INC. | $16.71 | 2019 | |
| Biodelivery Sciences International, INC. | $16.08 | 2019 | |
| Globus Medical, INC. | $14.84 | 2020 | |
| Shionogi INC | $12.50 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.99 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.